Search details
1.
Fasting-mimicking diet and hormone therapy induce breast cancer regression.
Nature
; 583(7817): 620-624, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32669709
2.
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC).
PLoS Genet
; 19(1): e1010563, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36595552
3.
Modulation of SLFN11 induces changes in DNA Damage response in breast cancer.
Cancer Cell Int
; 23(1): 291, 2023 Nov 24.
Article
in English
| MEDLINE | ID: mdl-38001424
4.
DECRESCENDO: de-escalating chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancer.
Future Oncol
; 19(24): 1655-1667, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37609714
5.
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting.
Int J Mol Sci
; 24(5)2023 Feb 21.
Article
in English
| MEDLINE | ID: mdl-36901733
6.
Impact of obesity and white adipose tissue inflammation on the omental microenvironment in endometrial cancer.
Cancer
; 128(18): 3297-3309, 2022 09 15.
Article
in English
| MEDLINE | ID: mdl-35793549
7.
HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet.
Histochem Cell Biol
; 158(6): 535-543, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-35902421
8.
Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study.
J Transl Med
; 20(1): 230, 2022 05 14.
Article
in English
| MEDLINE | ID: mdl-35568887
9.
Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues.
Gynecol Oncol
; 165(2): 239-247, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35292180
10.
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma.
Int J Mol Sci
; 23(24)2022 Dec 16.
Article
in English
| MEDLINE | ID: mdl-36555667
11.
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Lancet Oncol
; 22(4): 476-488, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33721561
12.
Author Correction: Fasting-mimicking diet and hormone therapy induce breast cancer regression.
Nature
; 588(7839): E33, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-33273708
13.
Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer.
Int J Mol Sci
; 22(13)2021 Jul 01.
Article
in English
| MEDLINE | ID: mdl-34281208
14.
A modular framework for the development of targeted Covid-19 blood transcript profiling panels.
J Transl Med
; 18(1): 291, 2020 07 31.
Article
in English
| MEDLINE | ID: mdl-32736569
15.
Correction to: Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer.
Breast Cancer Res Treat
; 177(3): 773, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31300923
16.
Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer.
Breast Cancer Res Treat
; 177(2): 335-343, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-31222709
17.
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer.
J Transl Med
; 17(1): 137, 2019 04 29.
Article
in English
| MEDLINE | ID: mdl-31036005
18.
Transcriptomic and genomic features of invasive lobular breast cancer.
Semin Cancer Biol
; 44: 98-105, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28400203
19.
Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer.
J Transl Med
; 15(1): 199, 2017 10 02.
Article
in English
| MEDLINE | ID: mdl-28969705
20.
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases.
J Transl Med
; 15(1): 91, 2017 05 01.
Article
in English
| MEDLINE | ID: mdl-28460632